IT1196348B - Composti ad attivita'antiinfiammatoria - Google Patents

Composti ad attivita'antiinfiammatoria

Info

Publication number
IT1196348B
IT1196348B IT23799/84A IT2379984A IT1196348B IT 1196348 B IT1196348 B IT 1196348B IT 23799/84 A IT23799/84 A IT 23799/84A IT 2379984 A IT2379984 A IT 2379984A IT 1196348 B IT1196348 B IT 1196348B
Authority
IT
Italy
Prior art keywords
compounds
inflammatory activity
inflammatory
activity
Prior art date
Application number
IT23799/84A
Other languages
English (en)
Italian (it)
Other versions
IT8423799A0 (it
Inventor
Giancarlo Sportoletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of IT8423799A0 publication Critical patent/IT8423799A0/it
Priority to IT23799/84A priority Critical patent/IT1196348B/it
Priority to GR852834A priority patent/GR852834B/el
Priority to JP61500163A priority patent/JPS62501703A/ja
Priority to PCT/EP1985/000645 priority patent/WO1986003199A1/en
Priority to ZA859035A priority patent/ZA859035B/xx
Priority to AU52311/86A priority patent/AU5231186A/en
Priority to EP86900097A priority patent/EP0236329A1/de
Priority to PT81566A priority patent/PT81566B/pt
Priority to CN198585109554A priority patent/CN85109554A/zh
Priority to ES549359A priority patent/ES8701717A1/es
Priority to DK346486A priority patent/DK346486A/da
Priority to KR1019860700507A priority patent/KR870700608A/ko
Application granted granted Critical
Publication of IT1196348B publication Critical patent/IT1196348B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT23799/84A 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria IT1196348B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria
GR852834A GR852834B (de) 1984-11-29 1985-11-25
EP86900097A EP0236329A1 (de) 1984-11-29 1985-11-26 Aminosalicylsäurederivate und pharmazeutische zusammensetzungen
PCT/EP1985/000645 WO1986003199A1 (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives and pharmaceutical compositions
ZA859035A ZA859035B (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives,salts thereof,process for their preparation and pharmaceutical compositions containing them
AU52311/86A AU5231186A (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them
JP61500163A JPS62501703A (ja) 1984-11-29 1985-11-26 アミノ−サリチル酸誘導体、その塩、それらの製法およびそれらを含有する医薬組成物
PT81566A PT81566B (en) 1984-11-29 1985-11-27 Process for preparing amino-salicylic acid derivatives
CN198585109554A CN85109554A (zh) 1984-11-29 1985-11-27 氨基水杨酸衍生物及其盐和其药用组合物的制备方法
ES549359A ES8701717A1 (es) 1984-11-29 1985-11-28 Un procedimiento para la preparacion de nuevos derivados del acido (5-amino-2-hidroxi)benzoico.
DK346486A DK346486A (da) 1984-11-29 1986-07-21 Aminosalicylsyrederivater og farmaceutiske midler
KR1019860700507A KR870700608A (ko) 1984-11-29 1986-07-28 아미노-살리실산 유도체 및 제약 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria

Publications (2)

Publication Number Publication Date
IT8423799A0 IT8423799A0 (it) 1984-11-29
IT1196348B true IT1196348B (it) 1988-11-16

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria

Country Status (12)

Country Link
EP (1) EP0236329A1 (de)
JP (1) JPS62501703A (de)
KR (1) KR870700608A (de)
CN (1) CN85109554A (de)
AU (1) AU5231186A (de)
DK (1) DK346486A (de)
ES (1) ES8701717A1 (de)
GR (1) GR852834B (de)
IT (1) IT1196348B (de)
PT (1) PT81566B (de)
WO (1) WO1986003199A1 (de)
ZA (1) ZA859035B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (it) * 1990-09-12 1994-09-12 Depha Team Srl Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (fr) * 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
AU2000241494B2 (en) * 2000-04-19 2005-03-17 Gnt Pharma Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
US6964982B2 (en) 2000-04-20 2005-11-15 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
DE60114724T2 (de) * 2000-07-18 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose
DE60141725D1 (de) 2001-01-19 2010-05-12 Apex Biotechnology Corp Nicht enzymatischer Einwegerkennungselektrodenstreifen der einen oberflächenaktiven Stoff beinhaltet, zum Nachweis von Harnsäure; Herstellungsverfahren dafür und Verwendung davon
CN101851173A (zh) 2001-09-14 2010-10-06 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
DK1551793T3 (en) 2002-06-19 2016-04-25 Gnt Pharma Co Ltd Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system
KR100668111B1 (ko) 2005-07-28 2007-01-12 (주)에스에이치제약 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법
US8455470B2 (en) * 2006-04-13 2013-06-04 Neurotech Pharmaceuticals Co., Ltd Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
CN100422721C (zh) * 2006-05-26 2008-10-01 南京大学 一种利用糖基萘酚的铝离子检测方法
CN102872020A (zh) * 2007-10-23 2013-01-16 株式会社医药分子设计研究所 Pai-1产生抑制剂
KR100852962B1 (ko) 2007-11-12 2008-08-20 주식회사 뉴로테크 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
ES2656903T3 (es) * 2008-07-08 2018-02-28 Catabasis Pharmaceuticals, Inc. Salicilatos acetilados de ácidos grasos y sus usos
KR101204108B1 (ko) * 2009-02-09 2012-11-22 주식회사 지엔티파마 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
NZ599067A (en) 2009-09-01 2014-04-30 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses
CN104603100A (zh) * 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 用于治疗炎症性肠病的组合物和方法
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
EP3902536A4 (de) * 2018-12-28 2022-09-28 GNT Pharma Co., Ltd Zusammensetzungen und verfahren zur behandlung von neurodegenerativen störungen
CN111116395B (zh) * 2019-12-27 2023-04-07 湖北工业大学 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (de) * 1964-06-09 1966-11-02
NL7008623A (de) * 1969-06-25 1970-12-29
JPS5640710B2 (de) * 1973-01-18 1981-09-22
JPS6056130B2 (ja) * 1978-03-20 1985-12-09 久光製薬株式会社 新規なサリチル酸誘導体
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
JPS62501703A (ja) 1987-07-09
ES549359A0 (es) 1986-12-01
PT81566A (en) 1985-12-01
CN85109554A (zh) 1986-07-23
DK346486D0 (da) 1986-07-21
KR870700608A (ko) 1987-12-30
PT81566B (en) 1987-04-07
ZA859035B (en) 1986-08-27
ES8701717A1 (es) 1986-12-01
IT8423799A0 (it) 1984-11-29
GR852834B (de) 1986-03-27
EP0236329A1 (de) 1987-09-16
DK346486A (da) 1986-07-21
AU5231186A (en) 1986-06-18
WO1986003199A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
IT1196348B (it) Composti ad attivita'antiinfiammatoria
IT1176983B (it) Dipeptidi ad attivita' farmacologica
IT1196237B (it) Composti eterociclici ad attivita' erbicida
DK574685A (da) Aktive forbindelser
IT1190389B (it) Esapeptidi ad attivita' ipotensiva
IT1186717B (it) Benzoil-uree ad attivita' insetticida
IT8247881A0 (it) Antinfiammatoria amidi pirrolacetiche ad attivita'
IT1187756B (it) Isoindolinil-alchil-piperazine ad attivita' farmaceutica
IT1183061B (it) Composti dotati di attivita'antiallergica
DE3563757D1 (de) Support d'enroulements
DE3565983D1 (de) N-arylsulfonyl-n'-triazinyl- and -pyrimidinyl ureas
IT8519585A0 (it) Promedicinali di ossicam antiinfiammatorie
IT1186772B (it) Composto ad attivita' pilostimolante
IT8420466A0 (it) Composti ad attivita'cardiotrofica.
IT8420075A0 (it) Composti ad attivita'antibatterica.
IT8419683A0 (it) Composti ad attivita'ipolipemizzante.
IT8419682A0 (it) Composti ad attivita'ipolipemizzante.
IT1173196B (it) Composti imidazopiridinici farmacologicamente attivi
IT1170276B (it) Composti ad attivita' antiinfiammatoria
LV5402A3 (lv) Kardioprotektors "Mildonats"
FR2564872B1 (fr) Borne d'arpentage
IT1176635B (it) Composti eterociclici ad attivita' erbicida
IT8522705A0 (it) Azolilderivati ad attivita'antufungina.
IT1163092B (it) Nuovi composti ad attivita' mucoregolatrice
IT8424252A0 (it) Composizioni farmaceutiche topiche ad attivita' antiinfiammatoria